These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1678583)

  • 1. Clenbuterol, a beta 2-receptor agonist, reduces net bone loss in denervated hindlimbs.
    Zeman RJ; Hirschman A; Hirschman ML; Guo G; Etlinger JD
    Am J Physiol; 1991 Aug; 261(2 Pt 1):E285-9. PubMed ID: 1678583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clenbuterol, a beta 2-agonist, retards wasting and loss of contractility in irradiated dystrophic mdx muscle.
    Zeman RJ; Zhang Y; Etlinger JD
    Am J Physiol; 1994 Sep; 267(3 Pt 1):C865-8. PubMed ID: 7943213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preservation of denervated muscle form and function by clenbuterol in a rat model of peripheral nerve injury.
    Fitton AR; Berry MS; McGregor AD
    J Hand Surg Br; 2001 Aug; 26(4):335-46. PubMed ID: 11469836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clenbuterol, a beta2-adrenoceptor agonist, reduces scoliosis due to partial transection of rat spinal cord.
    Zeman RJ; Zhang Y; Etlinger JD
    Am J Physiol; 1997 Apr; 272(4 Pt 1):E712-5. PubMed ID: 9142894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clenbuterol attenuates muscle atrophy and dysfunction in hindlimb-suspended rats.
    Dodd SL; Koesterer TJ
    Aviat Space Environ Med; 2002 Jul; 73(7):635-9. PubMed ID: 12137098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe bone alterations under beta2 agonist treatments: bone mass, microarchitecture and strength analyses in female rats.
    Bonnet N; Benhamou CL; Brunet-Imbault B; Arlettaz A; Horcajada MN; Richard O; Vico L; Collomp K; Courteix D
    Bone; 2005 Nov; 37(5):622-33. PubMed ID: 16157516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clenbuterol, a beta 2-agonist, retards atrophy in denervated muscles.
    Zeman RJ; Ludemann R; Etlinger JD
    Am J Physiol; 1987 Jan; 252(1 Pt 1):E152-5. PubMed ID: 3812670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of salbutamol and clenbuterol on skeletal muscle mass and carcass composition in senescent rats.
    Carter WJ; Lynch ME
    Metabolism; 1994 Sep; 43(9):1119-25. PubMed ID: 7916118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta adrenoceptor agonists, clenbuterol, and isoproterenol retard denervation atrophy in rat gastrocnemius muscle: use of 3-methylhistidine as a marker of myofibrillar degeneration.
    Agrawal S; Thakur P; Katoch SS
    Jpn J Physiol; 2003 Jun; 53(3):229-37. PubMed ID: 14529584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibited longitudinal growth of bones in young male rats by clenbuterol.
    Kitaura T; Tsunekawa N; Kraemer WJ
    Med Sci Sports Exerc; 2002 Feb; 34(2):267-73. PubMed ID: 11828236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clenbuterol prevents or inhibits loss of specific mRNAs in atrophying rat skeletal muscle.
    Babij P; Booth FW
    Am J Physiol; 1988 May; 254(5 Pt 1):C657-60. PubMed ID: 2834957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the beta 2-adrenergic agonist clenbuterol on capillary geometry in cardiac and skeletal muscles in young and middle-aged rats.
    Suzuki J; Gao M; Xie Z; Koyama T
    Acta Physiol Scand; 1997 Nov; 161(3):317-26. PubMed ID: 9401584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-agonist-induced alterations in organ weights and protein content: comparison of racemic clenbuterol and its enantiomers.
    von Deutsch DA; Abukhalaf IK; Wineski LE; Aboul-Enein HY; Pitts SA; Parks BA; Oster RA; Paulsen DF; Potter DE
    Chirality; 2000 Aug; 12(8):637-48. PubMed ID: 10897101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological evidences of reparative and regenerative effects of beta-adrenoceptor agonists, clenbuterol and isoproterenol, in denervated rat skeletal muscle.
    Katoch SS; Garg A; Sharma S
    Indian J Exp Biol; 2006 Jun; 44(6):448-58. PubMed ID: 16784115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol.
    Kline WO; Panaro FJ; Yang H; Bodine SC
    J Appl Physiol (1985); 2007 Feb; 102(2):740-7. PubMed ID: 17068216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clenbuterol in the prevention of muscle atrophy: a study of hindlimb-unweighted rats.
    Herrera NM; Zimmerman AN; Dykstra DD; Thompson LV
    Arch Phys Med Rehabil; 2001 Jul; 82(7):930-4. PubMed ID: 11441380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aminohydroxybutane bisphosphonate and clenbuterol prevent bone changes and retard muscle atrophy respectively in tail-suspended rats.
    Apseloff G; Girten B; Walker M; Shepard DR; Krecic ME; Stern LS; Gerber N
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1071-8. PubMed ID: 8450451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of clenbuterol on normal and denervated muscle growth and contractility.
    Agbenyega ET; Wareham AC
    Muscle Nerve; 1990 Mar; 13(3):199-203. PubMed ID: 2320041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of clenbuterol on bone metabolism in exercised or sedentary rats.
    Cavalié H; Lac G; Lebecque P; Chanteranne B; Davicco MJ; Barlet JP
    J Appl Physiol (1985); 2002 Dec; 93(6):2034-7. PubMed ID: 12433936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of clenbuterol on insulin resistance in conscious obese Zucker rats.
    Pan SJ; Hancock J; Ding Z; Fogt D; Lee M; Ivy JL
    Am J Physiol Endocrinol Metab; 2001 Apr; 280(4):E554-61. PubMed ID: 11254461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.